A spotlight on medicines for children
Date: Wednesday, 24 May 2023
Time: 18:30-20:00
Venue: Hotel Warwick, rue de Lausanne 14, 1201 Geneva
Convened by the Drugs for Neglected Diseases initiative (DNDi), the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), and the Medicines Patent Pool (MPP) on behalf of the Global Accelerator for Paediatric Formulations (GAP-f), this World Health Assembly side event will highlight promising efforts to address innovation and access to paediatric medicines. The event will serve as the basis for continued advocacy by GAP-f and its partners, with a goal to reviving the 2016 WHA resolution 69.201 on “Promoting innovation and access to quality, safe, efficacious and affordable medicines for children” and inclusion in the agenda of a future WHA.
Agenda
Opening
- Luis Pizarro, Executive Director, DNDi
- John Reeder, Director of TDR, the Special Programme for Research and Training in Tropical Diseases, WHO, and DNDi Board Permanent Observer
Barriers and opportunities to accelerate introduction and roll out of paeditric drug formulations
Facilitator: Charles Gore, Executive Director, Medicines Patent Pool
Experience from countries including Canada, Malaysia, and Pakistan
Panel discussion addressing a fragmented landscape of paediatric drug innovation and access
Facilitator: Carmen Pérez Casas, Senior Technical Manager, Strategy, Unitaid and member of the DNDi Access Committee
Speakers:
- Carlo Giaquinto, President, PENTA Foundation
- Jayasree Iyer, CEO, Access to Medicines Foundation and member of the DNDi Access Committee
- Jamie Bay Nishi, Executive Director, Global Health Technologies Coalition (GHTC)
- Anil Soni, Chief Executive Officer, WHO Foundation
Closing remarks
Chips Lyons, President & CEO, Elizabeth Glaser Pediatric AIDS Foundation
